Since the shelterin is TRF-1-dependent, TRF-1 inhibitors, or inhibitors of bREF and ERK2 kinase, which are associated with TRF-1 phosphorylation, might induce telomere damage and inhibit tumor growth. The gene discussed is MAPK1; the disease is neoplasm.